Literature DB >> 6508523

Late ovarian metastases in carcinoma of the colon and rectum.

M Morrow, W E Enker.   

Abstract

We reviewed 63 patients with metachronous ovarian metastases from colorectal carcinoma to determine the natural history of this problem, and whether aggressive surgical treatment is beneficial. Ovarian metastases usually occurred in younger patients (mean age, 51 years) and in 55.5% of the patients, the metastases were part of diffuse intra-abdominal disease. The mean survival rate for all patients following surgery was 16.6 months. The survival rate did not correlate with menstrual status, interval to recurrence, or Dukes' stage of the original cancer. Ability to remove all gross disease at the time of oophorectomy was the major determinant of survival. Surviving patients who were rendered disease free surgically (n = 15) lived a mean of 48 months compared with 9.6 months for patients with localized, but unresectable disease (n = 9), and eight months for patients with diffuse disease (n = 35). Surgical attempts to remove all gross disease seem to result in significantly improved survival rates even though a cure is rare. Bilateral oophorectomy is warranted as part of the palliative treatment of women who are seen with stage D cancers to prevent the development of large symptomatic metastases that require further therapy.

Entities:  

Mesh:

Year:  1984        PMID: 6508523     DOI: 10.1001/archsurg.1984.01390240023004

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  7 in total

1.  Oophorectomy in primary colorectal cancer.

Authors:  A Schofield; J Pitt; G Biring; P M Dawson
Journal:  Ann R Coll Surg Engl       Date:  2001-03       Impact factor: 1.891

2.  Ovarian metastases in young women with colorectal cancer: a retrospective multicenter cohort study.

Authors:  R van der Meer; C Bakkers; J A Wegdam; T Lettinga; E G Boerma; F Aarts; I H J T de Hingh; R M H Roumen
Journal:  Int J Colorectal Dis       Date:  2022-07-20       Impact factor: 2.796

3.  Reoperation for recurrent colorectal cancer.

Authors:  Michael D Hellinger; Cesar A Santiago
Journal:  Clin Colon Rectal Surg       Date:  2006-11

4.  Use of MoAb D612 in combination with a panel of MoAb for the immunocytochemical identification of metastases from colon-rectum carcinoma.

Authors:  M Mottolese; I Venturo; G Digiesi; R Perrone Donnorso; A Bigotti; R Muraro; A Aluffi; P G Natali
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

5.  Clinical analysis of Krukenberg tumours in patients with colorectal cancer-a review of 57 cases.

Authors:  K Y Xu; H Gao; Z J Lian; L Ding; M Li; J Gu
Journal:  World J Surg Oncol       Date:  2017-01-14       Impact factor: 2.754

6.  A case of metachronous left ovarian metastasis 8 years after surgery for cecal cancer and right ovarian metastasis: Report of a case.

Authors:  Itaru Shigeyoshi; Koji Komori; Takashi Kinoshita; Taihei Oshiro; Seiji Ito; Tetsuya Abe; Yoshiki Senda; Kazunari Misawa; Yuichi Ito; Norihisa Uemura; Seiji Natsume; Jiro Kawakami; Akira Ouchi; Masayuki Tsutsuyama; Takahiro Hosoi; Tomoyuki Akazawa; Daisuke Hayashi; Hideharu Tanaka; Yasushi Yatabe; Yasuhiro Shimizu
Journal:  Nagoya J Med Sci       Date:  2017-02       Impact factor: 1.131

7.  Surgical resection for small bowel obstruction due to right ovarian metastasis after ileocecal resection for cecal cancer: A case report.

Authors:  Naohiko Otsuka; Kimiyuki Shirayama
Journal:  Clin Case Rep       Date:  2022-03-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.